Skip to main content
Ingrid Scott, MD, Ophthalmology, Hershey, PA

IngridUScottMD

Ophthalmology Hershey, PA

Professor, Ophthalmology, Pennsylvania State University College of Medicine

Dr. Scott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Scott's full profile

Already have an account?

  • Office

    500 University Dr
    Hershey, PA 17033
    Phone+1 717-531-5690
    Fax+1 717-531-5009

Education & Training

  • University of Miami/Jackson Health System/Bascom Palmer Eye Institute
    University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1994 - 1997
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsInternship, Internal Medicine, 1993 - 1994
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1993

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1994 - 2027
  • PA State Medical License
    PA State Medical License 2005 - 2024
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Video-Conference Interviewing for the Ophthalmology Residency Match  
    Ingrid Scott, MD, JAMA Ophthalmology

Press Mentions

  • What Is Private Equity and Why Should Its Increasing Presence in Ophthalmology Matter?
    What Is Private Equity and Why Should Its Increasing Presence in Ophthalmology Matter?August 1st, 2024
  • Full-Thickness Macular Hole in a Pediatric Patient with Normal Vision
    Full-Thickness Macular Hole in a Pediatric Patient with Normal VisionAugust 1st, 2024
  • Simultaneous Intravitreal Steroid and Anti-VEGF Therapy for Monotherapy-Resistant Chronic Wet Age-Related Macular Degeneration
    Simultaneous Intravitreal Steroid and Anti-VEGF Therapy for Monotherapy-Resistant Chronic Wet Age-Related Macular DegenerationAugust 1st, 2024
  • Join now to see all

Professional Memberships